Lolli, Graziano
 Distribuzione geografica
Continente #
NA - Nord America 3.848
AS - Asia 1.329
EU - Europa 1.008
SA - Sud America 206
Continente sconosciuto - Info sul continente non disponibili 160
AF - Africa 29
OC - Oceania 3
Totale 6.583
Nazione #
US - Stati Uniti d'America 3.791
SG - Singapore 648
IT - Italia 269
CN - Cina 260
RU - Federazione Russa 187
VN - Vietnam 184
BR - Brasile 172
SE - Svezia 103
GB - Regno Unito 90
DE - Germania 81
FI - Finlandia 73
FR - Francia 59
LV - Lettonia 50
KR - Corea 44
BD - Bangladesh 35
CA - Canada 35
HK - Hong Kong 31
IN - India 25
ID - Indonesia 20
NL - Olanda 20
AR - Argentina 17
IQ - Iraq 16
TR - Turchia 15
JP - Giappone 14
BG - Bulgaria 13
MX - Messico 13
UA - Ucraina 11
PL - Polonia 9
ES - Italia 8
KE - Kenya 8
AT - Austria 6
JO - Giordania 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
MA - Marocco 5
CL - Cile 4
EC - Ecuador 4
EU - Europa 4
HR - Croazia 4
VE - Venezuela 4
AU - Australia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
LT - Lituania 3
MY - Malesia 3
PH - Filippine 3
SN - Senegal 3
AL - Albania 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
KH - Cambogia 2
NP - Nepal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
IE - Irlanda 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
TW - Taiwan 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 6.429
Città #
Ashburn 431
Singapore 398
Fairfield 382
Chandler 341
San Jose 211
Woodbridge 168
San Mateo 164
Wilmington 151
Houston 140
Seattle 125
Santa Clara 123
Dallas 118
Cambridge 110
Columbus 105
Moscow 90
Princeton 85
Council Bluffs 71
The Dalles 59
Los Angeles 56
Ann Arbor 54
Beijing 54
Trento 54
Helsinki 49
Riga 49
Ho Chi Minh City 45
New York 44
Seoul 43
Lauterbourg 41
Hanoi 38
Jacksonville 36
London 30
San Diego 28
Como 24
Bremen 21
Hong Kong 21
Buffalo 20
Munich 20
Orem 20
Da Nang 19
Milan 18
Falls Church 17
Jakarta 17
Washington 17
Dearborn 16
Fremont 16
Rome 14
Chicago 13
Montreal 13
Sofia 13
São Paulo 13
Toronto 13
San Francisco 12
Shanghai 11
Frankfurt am Main 10
Hefei 10
Brooklyn 9
Turku 9
Baghdad 8
Bologna 8
Dong Ket 8
Tokyo 8
Warsaw 8
Hangzhou 7
Nanjing 7
Rio de Janeiro 7
San Paolo di Civitate 7
Amsterdam 6
Bassano del Grappa 6
Denver 6
Guangzhou 6
Haiphong 6
Kilburn 6
Manchester 6
Monfalcone 6
New Delhi 6
Norwalk 6
Redondo Beach 6
Riva Del Garda 6
Salt Lake City 6
Trieste 6
Wuhan 6
Boston 5
Brasília 5
Bến Tre 5
Campinas 5
Chennai 5
Elk Grove Village 5
Hillsboro 5
Izmir 5
Nairobi 5
Phoenix 5
Stockholm 5
Altamura 4
Atlanta 4
Boardman 4
Carapicuíba 4
Dhaka 4
Kunming 4
Lancaster 4
Mexico City 4
Totale 4.524
Nome #
Discovery of Inhibitors of Four Bromodomains by Fragment-Anchored Ligand Docking 299
Pharmacological inactivation of the prion protein by targeting a folding intermediate 253
High-Throughput Fragment Docking into the BAZ2B Bromodomain: Efficient in Silico Screening for X-Ray Crystallography 235
The "gatekeeper" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains 213
Structural Analysis of Small-Molecule Binding to the BAZ2A and BAZ2B Bromodomains 213
Biochemical and cellular mechanism of protein kinase CK2 inhibition by deceptive curcumin 211
Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery 210
Discovery of BAZ2A bromodomain ligands 206
The STAS domain of mammalian SLC26A5 prestin harbours an anion-binding site 191
Structural characterization of the STAS domain of prestin. 175
A novel class of selective CK2 inhibitors targeting its open hinge conformation 174
Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface 171
Flavopiridol binding to P-TEFb (CDK9/cyclin T1) 169
Derivatives of 3-Amino-2-methylpyridine as BAZ2B Bromodomain Ligands: In Silico Discovery and in Crystallo Validation 169
Auto-inhibitory assembly of protein kinase CK2 revealed by X-ray crystallography. 167
Characterization of the oligomeric states of the CK2 α2β2 holoenzyme in solution 166
Structural Basis of CK2 Regulation by Autoinhibitory Oligomerization 165
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight 155
CAK—Cyclin-Dependent Activating Kinase: A Key Kinase in Cell Cycle Control and a Target for Drugs? 150
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: Structural features and pharmacological potential 148
Different orientations of low-molecular-weight fragments in the binding pocket of a BRD4 bromodomain 140
Pliability in the m6A-Binding Region Extends Druggability of YTH Domains 135
Identification of a BAZ2A Bromodomain Hit Compound by Fragment Joining 134
GroEL from the psychrophilic bacterium Pseudoalteromonas haloplanktis TAC 125: molecular characterization and gene cloning 132
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states 125
Small-Molecule Ebselen Binds to YTHDF Proteins Interfering with the Recognition of N 6-Methyladenosine-Modified RNAs 125
Active Form of the Protein Kinase CK2 alpha(2)beta(2) holoenzyme Is a Strong Complex with Symmetric Architecture 124
The Crystal Structure of Human CDK7 and Its Protein Recognition Properties 113
Molecular architecture of the glycogen- committed PP1/PTG holoenzyme 111
Insight into GFPmut2 pH Dependence by Single Crystal Microspectrophotometry and X-ray Crystallography 111
Inhibitory Properties of ATP-Competitive Coumestrol and Boldine Are Correlated to Different Modulations of CK2 Flexibility 111
Binding to DNA of the RNA-polymerase II C-Terminal Domain allows discrimination between Cdk7 ad Cdk9 phosphorylation 109
Identification of a BAZ2A-Bromodomain Hit Compound by Fragment Growing 92
Reevaluation of bromodomain ligands targeting BAZ2A 91
Inhibitor affinity chromatography: Profiling the specific reactivity of the proteome with immobilized molecules 89
PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability 87
Enhanced cellular death in liver and breast cancer cells by dual BET/BRPF1 inhibitors 79
Structural Determinants of Protein Kinase CK2 Regulation by Autoinhibitory Polymerization 77
Recognition of Cdk2 by Cdk7 74
Unprecedented Selectivity and Structural Determinants of a New Class of Protein Kinase CK2 Inhibitors in Clinical Trials for the Treatment of Cancer 71
New directions for CDKs and HDACs inhibition in cancer therapy 69
Mapping cryptic phosphorylation sites in the human proteome 68
Structure and single crystal spectroscopy of Green Fluorescent Proteins 65
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation 65
Structural dissection of cyclin dependent kinases regulation and protein recognition properties 62
Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2 61
The lysine-specific demethylase 1 is a novel substrate of protein kinase CK2 55
Structural and functional determinants of protein kinase CK2 alpha: facts and open questions 51
Protein glycosylation and synaptic transmission: brain glycogen keeps them separated 38
Switching off CK2-mediated activation of survivin offers new therapeutic opportunities in neuroblastoma 35
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient 28
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 16
Totale 6.583
Categoria #
all - tutte 31.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.086
Totale 32.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022627 0 68 3 20 61 28 15 182 37 81 40 92
2022/2023698 94 78 6 106 67 118 1 65 108 16 26 13
2023/2024317 22 33 47 11 32 65 12 19 2 19 8 47
2024/20251.177 18 23 64 222 78 153 38 29 140 256 97 59
2025/20262.178 138 51 222 305 220 193 367 64 180 225 130 83
2026/2027197 94 103 0 0 0 0 0 0 0 0 0 0
Totale 6.583